CN113750108B - 用于过重女性患者的基于屈螺酮的避孕药 - Google Patents

用于过重女性患者的基于屈螺酮的避孕药

Info

Publication number
CN113750108B
CN113750108B CN202111154721.4A CN202111154721A CN113750108B CN 113750108 B CN113750108 B CN 113750108B CN 202111154721 A CN202111154721 A CN 202111154721A CN 113750108 B CN113750108 B CN 113750108B
Authority
CN
China
Prior art keywords
contraceptive
drsp
drospirenone
women
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111154721.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN113750108A (zh
Inventor
D·德鲁恩
C·布瓦耶-茹贝尔
P·佩兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Leon Farma SA
Original Assignee
Laboratorios Leon Farma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN113750108(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Application filed by Laboratorios Leon Farma SA filed Critical Laboratorios Leon Farma SA
Publication of CN113750108A publication Critical patent/CN113750108A/zh
Application granted granted Critical
Publication of CN113750108B publication Critical patent/CN113750108B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202111154721.4A 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药 Active CN113750108B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
EP15305965.4 2015-06-23
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN2015103489531 2015-06-23
CN201680045547.0A CN108025014B (zh) 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680045547.0A Division CN108025014B (zh) 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药

Publications (2)

Publication Number Publication Date
CN113750108A CN113750108A (zh) 2021-12-07
CN113750108B true CN113750108B (zh) 2025-08-19

Family

ID=56178376

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202111154721.4A Active CN113750108B (zh) 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药
CN201680045547.0A Active CN108025014B (zh) 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680045547.0A Active CN108025014B (zh) 2015-06-23 2016-06-23 用于过重女性患者的基于屈螺酮的避孕药

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN113750108B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
CA2988362C (en) 2015-06-18 2022-07-19 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
PT3310333T (pt) 2015-06-18 2020-06-08 Estetra Sprl Dose unitária orodispersível contendo um composto de estetrol
TN2017000499A1 (en) 2015-06-18 2019-04-12 Mithra Pharmaceuticals S A Orodispersible dosage unit containing an estetrol component
CN113750108B (zh) 2015-06-23 2025-08-19 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
CN104208067A (zh) * 2004-07-07 2014-12-17 惠氏公司 周期性黄体酮方案及试剂盒
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
SI1746101T2 (sl) 2005-07-21 2014-09-30 Bayer Pharma Aktiengesellschaft Postopek za pripravo 3-okso-pregn-4-en-21,17-karbolaktonov z oksidacijo 17-(3-hidroksipropil)-3,17-dihidroksiandrostanov brez uporabe kovine
AU2008235006A1 (en) * 2007-04-05 2008-10-16 Bayer Schering Pharma Aktiengesellschaft New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
US8921346B2 (en) * 2010-03-16 2014-12-30 Taizhou Taifa Pharmaceuticals Co., Ltd. Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
CN113750108B (zh) 2015-06-23 2025-08-19 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000981A1 (en) * 2010-06-29 2012-01-05 Laboratorios Leon Farma Sa Pharmaceutical composition comprising drospirenone and contraceptive kit

Also Published As

Publication number Publication date
UA122873C2 (uk) 2021-01-13
AU2016282863A1 (en) 2018-02-08
PL3313408T3 (pl) 2024-04-15
HK1255216A1 (zh) 2019-08-09
KR102217942B1 (ko) 2021-02-19
KR20180019173A (ko) 2018-02-23
JP2018527305A (ja) 2018-09-20
NZ739195A (en) 2024-04-26
CA2989975C (en) 2021-10-12
LT3313408T (lt) 2024-03-12
EA036497B1 (ru) 2020-11-17
HRP20240121T8 (hr) 2024-05-10
EP3313408B1 (en) 2023-12-06
MY187233A (en) 2021-09-13
AU2016282863B2 (en) 2021-05-27
SMT202400062T1 (it) 2024-03-13
MX2017016801A (es) 2018-05-11
FI3313408T3 (fi) 2024-01-25
BR112017028048A2 (pt) 2018-09-04
ES2970532T3 (es) 2024-05-29
SI3313408T1 (sl) 2024-04-30
CN108025014A (zh) 2018-05-11
JP6827962B2 (ja) 2021-02-10
HUE065350T2 (hu) 2024-05-28
HRP20240121T1 (hr) 2024-04-12
ZA201800067B (en) 2019-07-31
EP3313408A1 (en) 2018-05-02
CA2989975A1 (en) 2016-12-29
PH12017502379A1 (en) 2018-06-25
WO2016207298A1 (en) 2016-12-29
MX389310B (es) 2025-03-20
SV2017005602A (es) 2018-08-14
CN108025014B (zh) 2021-10-22
NI201700173A (es) 2018-04-02
EA201792595A1 (ru) 2018-06-29
RS65196B1 (sr) 2024-03-29
DK3313408T3 (da) 2024-01-29
CN113750108A (zh) 2021-12-07

Similar Documents

Publication Publication Date Title
CN113750108B (zh) 用于过重女性患者的基于屈螺酮的避孕药
US11291633B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US11951213B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US10179140B2 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11413249B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
EP3108889A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928B (zh) 用於过重女性患者的基於屈螺酮的避孕药
HK1232778A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK1232778A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit
HK1255216B (zh) 用於过重女性患者的基於屈螺酮的避孕药
OA18512A (en) Drospirenone-based contraceptive for a female patient affected with excess weight.
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40061928

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant